Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, has been named to the ninth annual Fortune Small Business FSB 100 list of the fastest-growing small public companies in America.
Ms. Renee Bouche, Investor Relations Manager for Simulations Plus, noted: “The July/August issue of Fortune Small Business has just released its annual list of the 100 fastest-growing small public companies in America, and Simulations Plus is privileged to be making its first appearance. The list, comprised of U.S.-domiciled firms with annual revenues below $200 million and a stock price above $1, is based on revenue growth and stock performance over the past three years plus a new requirement this year of no negative growth in any of the most recent four quarters. In describing the accomplishments of the FSB 100, Fortune Small Business writes, ‘ . . . in this Great Recession, their performance is nothing short of miraculous . . . All 100 companies on our list have figured out how to succeed no matter what the economic climate.’ Simulations Plus was ranked 53rd.”
Walt Woltosz, chairman and chief executive officer of Simulations Plus, added, “This was unexpected and a pleasant surprise to be included in this prestigious list.”